Xuerong Wang

Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition

Shi-Yong Sun, Laura M. Rosenberg, Xuerong Wang et al. · Cancer Research · 2005 · 808 citations

Medicine, Oncology, Pharmacology +13

Tumor‐derived exosomal miR‐19b‐3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway

Jing Chen, Kai Zhang, Yingru Zhi et al. · Clinical and Translational Medicine · 2021 · 201 citations · Full text

Medicine, Cancer Biology, Oncology +14

EVI1 induces myelodysplastic syndrome in mice

Silvia Buonamici, Donglan Li, Yiqing Chi et al. · Journal of Clinical Investigation · 2004 · 181 citations

Life Sciences, Genetics, Hematology +17

Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation

Xuerong Wang, Ping Yue, Young Ae Kim et al. · Cancer Research · 2008 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of Mammalian Target of Rapamycin Induces Phosphatidylinositol 3-Kinase-Dependent and Mnk-Mediated Eukaryotic Translation Initiation Factor 4E Phosphorylation

Xuerong Wang, Ping Yue, Chi-Bun Chan et al. · Molecular and Cellular Biology · 2007 · 152 citations · Full text

Life Sciences, Molecular Biology, Oncology +17